UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 16, 2015 4:30 P.M.

Form:	S-3
CIK: 0001583107 Company Name: Theravance Biopharma, Inc. File Number: 333-205275
CIK: 0001646102 Company Name: Theravance Biopharma Antibiotics, Inc. File Number: 333-205275-06
CIK: 0001645881 Company Name: Theravance Biopharma Cayman Holdings, Inc. File Number: 333-205275-05
CIK: 0001645834 Company Name: Theravance Biopharma Ireland Ltd File Number: 333-205275-04
CIK: 0001645883 Company Name: Theravance Biopharma R&D, Inc. File Number: 333-205275-03
CIK: 0001645844 Company Name: Theravance Biopharma UK Ltd File Number: 333-205275-02
CIK: 0001645884 Company Name: Theravance Biopharma US, Inc. File Number: 333-205275-01